|
|
 |
Home : Leadership :
Guenther Karmann
Guenther Karmann, Ph.D
PROFESSIONAL CAREER
1988-2002 Bayer AG
1988-1990 Laboratory Head, Pharma Research Center,
Wuppertal
1990-1995 "Delegate", Bayer Corp., West Haven,
CT, USA
1990-1991 Laboratory Head
Discovery
of new target molecules for therapeutic intervention (cardiovascular
disease and diabetes)
1992-1993 Licensing manager
-
Member of strategic
team for starting new business segment "Cancer"
-
Identification of a
strategic partner, closure of collaboration with Onyx
Pharmaceuticals
1994-1995 Head of newly founded cancer research group
-
Management of external
collaborations (budget approx. US$ 6 Mio.)
-
Build-up of internal
group to 15 employees
-
Presentation of first
development candidate
1996-2002 Bayer AG, Central Research, Leverkusen
1996 Section Head "Biotechnology"
-
Responsible for 35
employees
-
Target identification
with genomics and bioinformatics, high-throughput screens
1996-2002 Department Head "Biotechnology", following
reorganization "Life Sciences"
-
Staff 100-180 employees
-
Enabling technologies
encompassing biology and chemistry (combinatorial, natural products)
-
Intensive collaboration
with business groups health care, fine chemicals and polymers
-
New pharmaceutical
targets and lead structures, diagnostic assays, biosynthetically
produced fine chemicals
2002-2006 Chief Executive Officer, DeveloGen AG,
Göttingen
-
Biopharmaceutical
company with focus on diabetes
-
Lead product against
type 1 diabetes in clinical phase III
-
Innovative development
candidates for the indication type 2 diabetes
-
Approx. 80 employees,
in Germany and Israel
11/2006
Foundation of Karmann Consulting GmbH
-
Providing services to the innovative health care industry
-
Working on mandates from capital firms, companies, government bureaus and academia
Copyright © 2004 Kinexum LLC | terms of use | privacy
|
|
|
